Goldman Sachs upgraded Tenet Healthcare (NYSE: THC) from Neutral to Buy with a price target of $55.00 (from $47.00), calling ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE